Correlation Between Reliance Communications and Kilitch Drugs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Reliance Communications and Kilitch Drugs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Reliance Communications and Kilitch Drugs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Reliance Communications Limited and Kilitch Drugs Limited, you can compare the effects of market volatilities on Reliance Communications and Kilitch Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Reliance Communications with a short position of Kilitch Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Reliance Communications and Kilitch Drugs.

Diversification Opportunities for Reliance Communications and Kilitch Drugs

-0.01
  Correlation Coefficient

Good diversification

The 3 months correlation between Reliance and Kilitch is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Reliance Communications Limite and Kilitch Drugs Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kilitch Drugs Limited and Reliance Communications is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Reliance Communications Limited are associated (or correlated) with Kilitch Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kilitch Drugs Limited has no effect on the direction of Reliance Communications i.e., Reliance Communications and Kilitch Drugs go up and down completely randomly.

Pair Corralation between Reliance Communications and Kilitch Drugs

Assuming the 90 days trading horizon Reliance Communications is expected to generate 5.96 times less return on investment than Kilitch Drugs. But when comparing it to its historical volatility, Reliance Communications Limited is 1.03 times less risky than Kilitch Drugs. It trades about 0.01 of its potential returns per unit of risk. Kilitch Drugs Limited is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  15,950  in Kilitch Drugs Limited on September 5, 2024 and sell it today you would earn a total of  16,445  from holding Kilitch Drugs Limited or generate 103.1% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy99.8%
ValuesDaily Returns

Reliance Communications Limite  vs.  Kilitch Drugs Limited

 Performance 
       Timeline  
Reliance Communications 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Reliance Communications Limited has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.
Kilitch Drugs Limited 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kilitch Drugs Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Kilitch Drugs is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Reliance Communications and Kilitch Drugs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Reliance Communications and Kilitch Drugs

The main advantage of trading using opposite Reliance Communications and Kilitch Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Reliance Communications position performs unexpectedly, Kilitch Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kilitch Drugs will offset losses from the drop in Kilitch Drugs' long position.
The idea behind Reliance Communications Limited and Kilitch Drugs Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets